About
Technology
Issues
FAQ
Links
Official Page
Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic mice
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.